VASCULAR PHARMACOLOGY

Scope & Guideline

Transforming insights into therapies for vascular diseases.

Introduction

Immerse yourself in the scholarly insights of VASCULAR PHARMACOLOGY with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1537-1891
PublisherELSEVIER SCIENCE INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2002 to 2024
AbbreviationVASC PHARMACOL / Vasc. Pharmacol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressSTE 800, 230 PARK AVE, NEW YORK, NY 10169

Aims and Scopes

Vascular Pharmacology focuses on the intersection of pharmacology and vascular health, addressing various cardiovascular conditions through innovative therapeutic strategies, molecular mechanisms, and clinical applications.
  1. Pharmacological Interventions in Cardiovascular Diseases:
    The journal emphasizes the exploration of pharmacological agents and their impacts on cardiovascular diseases, including antiplatelet therapies, anticoagulants, statins, and novel drugs like PCSK9 inhibitors and SGLT2 inhibitors.
  2. Mechanisms of Vascular Disease:
    Research published in the journal delves into the cellular and molecular mechanisms underpinning vascular diseases, exploring inflammation, oxidative stress, and metabolic dysfunction as key contributors.
  3. Clinical Trials and Systematic Reviews:
    The journal regularly features systematic reviews and clinical trial results, providing evidence-based insights into the efficacy and safety of new treatment strategies and interventions for cardiovascular conditions.
  4. Emerging Biomarkers and Risk Factors:
    A focus on identifying novel biomarkers and cardiovascular risk factors is prevalent, aiding in the early detection and management of vascular diseases.
  5. Interdisciplinary Approaches to Cardiovascular Health:
    Vascular Pharmacology encourages interdisciplinary research that integrates insights from cardiology, pharmacology, endocrinology, and nutrition to address complex cardiovascular health issues.
Recent publications in Vascular Pharmacology reveal several emerging themes and trends that highlight the evolving landscape of cardiovascular research.
  1. Impact of Gut Microbiota on Cardiovascular Health:
    There is a growing interest in understanding how gut microbiota influences cardiovascular health, with studies exploring dietary modifications and postbiotics as therapeutic strategies.
  2. Personalized Medicine in Cardiovascular Care:
    A trend towards personalized medicine is evident, with increasing research on pharmacogenomics and tailored treatment strategies for individual patients based on genetic and metabolic profiles.
  3. Role of Inflammation in Cardiovascular Disease:
    Inflammation continues to be a focal point in recent studies, with novel insights into how inflammatory pathways contribute to vascular pathology and how targeting these pathways can improve therapeutic outcomes.
  4. Longitudinal Studies on Cardiovascular Risk Factors:
    Emerging research emphasizes the importance of longitudinal studies to assess the burden of cardiovascular risk factors over time, particularly in specific populations such as those with diabetes or chronic kidney disease.
  5. Innovative Techniques in Vascular Imaging:
    There is an increasing emphasis on the development and application of advanced imaging techniques to better understand vascular diseases and improve diagnostic accuracy.

Declining or Waning

While Vascular Pharmacology has consistently focused on various aspects of cardiovascular health, certain themes appear to be declining in prominence based on recent publications.
  1. Historical Perspectives on Cardiovascular Therapies:
    There has been a noticeable decrease in articles focused on historical perspectives or reviews of past cardiovascular therapies, suggesting a shift towards more contemporary approaches and innovative treatments.
  2. Standalone Dietary Interventions:
    Research centered exclusively on dietary interventions without pharmacological context has become less common, indicating a trend towards integrated approaches that combine pharmacotherapy with lifestyle modifications.
  3. Basic Science without Clinical Application:
    The journal has seen a decline in purely basic science studies that do not translate into clinical application, reflecting a preference for research that directly informs clinical practice and patient care.

Similar Journals

Clinica e Investigacion en Arteriosclerosis

Elevating the standards of cardiovascular medicine through rigorous investigation.
Publisher: ELSEVIERISSN: 0214-9168Frequency: 6 issues/year

Clinica e Investigacion en Arteriosclerosis is a premier academic journal dedicated to the field of cardiology and cardiovascular medicine, published by ELSEVIER. With its ISSN 0214-9168 and E-ISSN 1578-1879, the journal aims to disseminate high-quality research and innovations in the understanding and treatment of arterial diseases, contributing significantly to both clinical practices and pharmacological advancements. Established in 2007 and continuing into 2024, the journal has garnered recognition with a notable Q3 categorization in both Cardiology and Cardiovascular Medicine and Pharmacology (medical) for 2023, reflecting its impact in the academic community. Researchers and healthcare professionals utilizing this journal will find a diverse range of articles exploring novel therapeutic strategies and epidemiological data, making it an essential resource for advancing knowledge and practice in cardiovascular health. While it does not operate as an open-access journal, the findings published in Clinica e Investigacion en Arteriosclerosis are pivotal for understanding current trends and future directions in cardiovascular research.

Kardiologia Polska

Connecting Global Minds in Heart Health Research
Publisher: POLISH CARDIAC SOCISSN: 0022-9032Frequency: 12 issues/year

Kardiologia Polska, the esteemed journal of the Polish Cardiac Society, has established itself as a vital resource in the field of cardiology and cardiovascular medicine since its inception in 1954. With an ISSN of 0022-9032 and an E-ISSN of 1897-4279, this journal serves as a platform for groundbreaking research and scholarly articles that contribute to the advancement of heart health. Although currently not an open access journal, it remains an essential reference for practitioners and researchers seeking to stay abreast of the latest developments in cardiovascular science. The journal reflects its scholarly depth through a Category Quartile of Q3 and a commendable Scopus ranking at the 48th percentile in its field. Published primarily in Poland, it caters to a global audience eager to explore comprehensive studies spanning clinical cardiology, innovative therapeutic approaches, and emerging cardiovascular trends. Join a thriving academic community by engaging with the invaluable insights and research contributions found within the pages of Kardiologia Polska.

JOURNAL OF VASCULAR RESEARCH

Advancing vascular knowledge since 1964.
Publisher: KARGERISSN: 1018-1172Frequency: 6 issues/year

Welcome to the JOURNAL OF VASCULAR RESEARCH, a reputable academic journal published by KARGER that has been a cornerstone of vascular research since 1964. With an ISSN of 1018-1172 and an E-ISSN of 1423-0135, this journal plays a vital role in disseminating cutting-edge research in the fields of Cardiology and Cardiovascular Medicine and Physiology. Currently categorized in the Q3 quartile for both disciplines, it ranks as #179 in Cardiology and #131 in Physiology according to Scopus, showcasing its significant contribution to the scientific community. Although the journal operates on a subscription basis, it strives to provide accessible content that informs and inspires researchers, professionals, and students alike. As the journal looks forward to its convergence in 2024, it continues to uphold its mission of advancing knowledge, fostering innovation, and encouraging collaboration within the dynamic realm of vascular research.

Clinical Medicine Insights-Cardiology

Elevating Cardiac Care with Groundbreaking Research
Publisher: SAGE PUBLICATIONS LTDISSN: 1179-5468Frequency: 1 issue/year

Clinical Medicine Insights-Cardiology is a prestigious open-access journal published by SAGE Publications Ltd, focusing on cutting-edge research in the field of cardiology and cardiovascular medicine. With the ever-evolving landscape of cardiovascular health, this journal serves as a vital platform for disseminating significant findings, clinical practices, and innovative therapies. Established in 2007, it has rapidly gained recognition, currently ranked in the Q2 category for cardiology, positioned at #112 out of 387 in Scopus Rankings, and boasting a commendable 71st percentile. The journal not only emphasizes the integration of recent advancements in clinical and laboratory studies but also aims to bridge the gap between research and practice, making it an essential resource for researchers, healthcare professionals, and students alike. Situated in New Zealand and operating with an open-access model, Clinical Medicine Insights-Cardiology promotes the unrestricted dissemination of knowledge, ensuring that critical insights into cardiovascular medicine are accessible globally.

Diabetes & Vascular Disease Research

Bridging the gap between diabetes and cardiovascular wellness.
Publisher: SAGE PUBLICATIONS LTDISSN: 1479-1641Frequency: 6 issues/year

Diabetes & Vascular Disease Research is a leading academic journal dedicated to advancing the understanding and treatment of cardiovascular and metabolic diseases, particularly diabetes. Published by SAGE Publications Ltd in the United Kingdom, this journal serves as a key resource for researchers, clinicians, and students seeking to explore the intricate relationship between diabetes and vascular health. With an impressive Impact Factor and ranked in the Q2 quartile in prominent categories such as Cardiology, Endocrinology, and Internal Medicine, the journal provides a platform for high-quality, peer-reviewed research. Covering a broad range of topics from pathophysiology to therapeutic innovations, Diabetes & Vascular Disease Research plays a vital role in shaping contemporary discourse in the field. With contributions from leading experts and a commitment to disseminating valuable findings, this journal is a must-read for anyone involved in the fight against vascular complications arising from diabetes.

Current Atherosclerosis Reports

Transforming cardiovascular care through rigorous research.
Publisher: CURRENT MEDICINE GROUPISSN: 1523-3804Frequency: 12 issues/year

Current Atherosclerosis Reports, published by CURRENT MEDICINE GROUP, is a leading scientific journal in the field of Cardiology and Cardiovascular Medicine, boasting an impressive Q1 ranking in its category as of 2023. This esteemed journal, with an ISSN of 1523-3804 and an E-ISSN of 1534-6242, has been a cornerstone of cardiovascular research since its inception in 1999, continuing to publish cutting-edge studies through 2024. With unparalleled insights into the mechanisms, prevention, and treatment of atherosclerosis, it serves as an essential resource for researchers, healthcare professionals, and students alike. Although not an open-access journal, it is highly regarded within the academic community, highlighted by its Scopus rank of #54 out of 387 in its field, placing it in the 86th percentile. The journal's commitment to advancing knowledge in cardiovascular health underscores its integral role in guiding clinical practices and influencing future research directions.

Cerebral Circulation-Cognition and Behavior

Exploring the Nexus of Mind and Motion
Publisher: ELSEVIERISSN: 2666-2450Frequency: 1 issue/year

Cerebral Circulation-Cognition and Behavior is an impactful journal published by Elsevier that focuses on the intersections of cerebral circulation, cognitive function, and behavioral science. Since its establishment in 2020, the journal has provided a vital platform for researchers and professionals in the fields of Behavioral Neuroscience, Biological Psychiatry, and Cognitive Neuroscience. With a current classification in the Q3 quartile across several neuroscience categories and a promising trajectory during its converged years (2020-2024), the journal highlights significant advancements in our understanding of the neural underpinnings of behavior. Although it is not open access, its commitment to quality research makes it an essential resource for anyone engaged in neurological, cognitive, and psychiatric studies. As discoveries in these fields continue to grow, Cerebral Circulation-Cognition and Behavior remains dedicated to disseminating influential findings that bridge the gap between cognition, behavior, and neural health.

International Heart Journal

Empowering Healthcare Professionals with Cutting-edge Insights
Publisher: INT HEART JOURNAL ASSOCISSN: 1349-2365Frequency: 6 issues/year

International Heart Journal, published by INT HEART JOURNAL ASSOC, serves as a pivotal platform for research and discourse in the fields of cardiology and cardiovascular medicine. With its ISSN 1349-2365 and E-ISSN 1349-3299, this esteemed journal is based in Japan and is located at the University of Tokyo, Graduate School of Medicine, Department of Cardiovascular Medicine. Since its inception in 2005, International Heart Journal has blossomed into a respected publication with an impact factor that signifies its growing relevance, ranking in the Q3 category of both cardiology and miscellaneous medicine as of 2023. This journal not only disseminates vital research findings but also fosters collaboration among researchers and healthcare professionals. Notable for its Open Access options, it ensures the availability of its content to a broader audience, thereby enhancing knowledge transfer and innovation in cardiovascular care. With an ongoing commitment to improve clinical practice and patient outcomes, the journal continues to be an essential resource for those dedicated to advancing the understanding of heart health and disease.

International Journal of Vascular Medicine

Transforming Vascular Medicine Through Collaborative Insights
Publisher: HINDAWI LTDISSN: 2090-2824Frequency: 1 issue/year

The International Journal of Vascular Medicine is a peer-reviewed, open access journal dedicated to advancing research and knowledge in the field of vascular medicine. Published by HINDAWI LTD and operating since 2010, this journal provides a platform for the dissemination of high-quality studies, reviews, and case reports related to cardiovascular health. Based in Egypt, the journal's comprehensive scope encompasses a range of topics within cardiology and cardiovascular medicine, with a current impact factor reflected by its Q3 ranking in 2023, positioning it among the noteworthy publications in its category. With a Scopus rank of 176 out of 387, the journal maintains a significant presence in the academic community, supported by a commitment to open access, ensuring that research is freely available to all stakeholders. Researchers, professionals, and students alike are encouraged to contribute to and engage with the International Journal of Vascular Medicine as it enhances the understanding and treatment of vascular diseases and promotes innovative practices within the field.

VASCULAR MEDICINE

Pioneering insights in vascular medicine for a healthier tomorrow.
Publisher: SAGE PUBLICATIONS LTDISSN: 1358-863XFrequency: 6 issues/year

Vascular Medicine is a premier academic journal for researchers and practitioners in the field of cardiovascular health, published by SAGE Publications Ltd. With an ISSN of 1358-863X and E-ISSN 1477-0377, this esteemed journal has been at the forefront of publishing quality research since its inception in 1992, with convergence extending to 2024. Ranked in the Q2 category for both Cardiology and Cardiovascular Medicine as well as for miscellaneous Medicine in 2023, it is recognized for its significant contributions to advancing knowledge and clinical practice within these domains. Its Scopus ranking situates it at #91 out of 387 in the field, reflecting its high impact and the relevance of its published research, which is crucial for addressing the challenges in vascular health today. Although it is not an open-access journal, Vascular Medicine remains dedicated to disseminating vital findings that bridge the gap between research and clinical application, making it an essential resource for medical researchers, healthcare professionals, and students alike.